Study S002163

The Chronic and Acute Postprandial Vascular Effects of Exenatide vs. Metformin in Abdominally Obese Patients With Impaired Glucose Tolerance

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT00546728
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 50
Start: 2007-10
Primary completion: 2011-07
Lead sponsor: St. Paul Heart Clinic
Conditions: Impaired Glucose Tolerance
Interventions: DRUG:Exenatide; DRUG:Metformin
Results posted: TRUE

Registered primary outcomes

Change in Reactive Hyperemic Index Over the 3-month Treatment Period [Change from baseline to 3 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0022862	Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial. Kelly AS, Cardiovascular diabetology	2012	Randomized trial	PMID 22681705 DOI	cites ClinicalTrials.gov:NCT00546728; registry reference DERIVED:22681705